Related Experiment Video
Updated: May 20, 2026
07:36
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
Published on: June 12, 2021
Know thy enemy: Why are tumor-infiltrating regulatory T cells so deleterious?
Andrea Facciabene1, Stephen Santoro, George Coukos
1Ovarian Cancer Research Center; Perelman School of Medicine; University of Pennsylvania; Philadelphia, USA.
Oncoimmunology
|July 4, 2012
Summary
Hypoxia drives regulatory T cell (Treg) recruitment in ovarian cancer via CCL28. These Tregs promote cancer progression by suppressing immunity and altering blood vessel growth, presenting therapeutic challenges and opportunities.
Area of Science:
- Oncology
- Immunology
- Cancer Biology
Background:
- Hypoxia is a key factor in the tumor microenvironment.
- Regulatory T cells (Tregs) are crucial in immune suppression within tumors.
- Ovarian cancer progression involves immune evasion and angiogenesis.
Purpose of the Study:
- To review the mechanisms by which hypoxia recruits Tregs in ovarian cancer.
- To discuss the role of Tregs in cancer progression, including immune paralysis and angiogenesis.
- To explore therapeutic strategies targeting Tregs in ovarian cancer.
Main Methods:
- Review of existing literature on hypoxia, Tregs, CCL28, and ovarian cancer.
- Analysis of Treg-mediated immune suppression mechanisms.
- Examination of Treg's role in tumor angiogenesis.
Main Results:
- Hypoxia is identified as a primary mechanism for Treg recruitment in ovarian cancer, mediated by the CCL28 chemokine.
- Tregs contribute to cancer progression through tumor-specific immune paralysis.
- Tregs also play a role in reprogramming tumor angiogenesis.
Conclusions:
- Targeting the hypoxia-Treg-CCL28 axis presents a potential therapeutic avenue in ovarian cancer.
- Understanding Treg-mediated immune suppression and angiogenesis is critical for developing effective ovarian cancer treatments.
- Further research is needed to overcome challenges and exploit opportunities in Treg-targeted therapies for ovarian cancer.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:40Cell-mediated Immune Responses
Overview
01:28Cells of the Innate Immune Response
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...